CClinicalTrials.gg
CompletedNCT02932358Updated Nov 23, 2018

Effectiveness and Safety of a Flexible Family Visitation Model for Delirium Prevention in Adult Intensive Care Units: a Cluster-randomized, Crossover Trial (The ICU Visits Study)

An interventional study of Flexible Family Visitation Model (FFVM) and Restrictive Family Visitation Model (RFVM) in Delirium, sponsored by Hospital Moinhos de Vento. Completed at 33 sites in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-11-23.

Sponsored by Hospital Moinhos de Vento · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,650
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A cluster-randomized crossover trial involving adult ICU patients, family members, and ICU professionals will be conducted. Forty medical-surgical Brazilian ICUs with visiting hours \<4.5 h/day will be randomly assigned to either a restrictive family visitation model (RFVM) (visits according to local policies) or a flexible family visitation model (FFVM) (visitation during 12 consecutive hours per day) at a 1:1 ratio. After enrollment and follow-up of 25 patients, each ICU will be switched over to the other visitation model, until 25 more patients per site are enrolled and followed. The primary outcome will be the cumulative incidence of delirium among ICU patients, measured twice a day using the Confusion Assessment Method for the ICU. Secondary outcome measures will include daily hazard of delirium, ventilator-free days at day 7, any ICU-acquired infections, ICU length of stay, and all-cause hospital mortality among the patients; symptoms of anxiety and depression and satisfaction among the family members; and prevalence of symptoms of burnout among the ICU professionals. Tertiary outcomes will include need for antipsychotic agents and/or mechanical restraints, coma-free days at day 7, unplanned loss of invasive devices, and ICU-acquired pneumonia, urinary tract infection, or bloodstream infection among the patients; self-perception of involvement in patient care among the family members; and satisfaction among the ICU professionals.

02

Conditions studied

  • Delirium

Browse trials for

Keywords

  • Intensive care units
  • Delirium
  • Cross infection
  • Mortality
  • Length of stay
  • Burnout, Professional
  • Depression
  • Anxiety
03

In context

Delirium

1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.

This study's enrollment of 1,650 is above the median of 120 across 599 interventional studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

Hospital Moinhos de Vento is the lead sponsor of 34 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • For ICUs: medical-surgical ICUs of of public and philanthropic Brazilian hospitals with restricted visitation policies(\<4.5 hours/day).
  • For Patients: Age ≥ 18 years, admission to the intensive care unit.
  • For Patient's Family Members: nearest relative of the ICU patient recruited in the study and consent to participate in the study.
  • For ICU Workers: ICU workers that assist patients in the ICU during the daytime for at least 20 hours per week and consent to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • For ICUs: ICUs with structural or organizational impediments to extended visitation.
  • For Patients: Subjects with coma (Richmond Agitation Sedation Scale -4 or -5) lasting > 96 hours from the moment of first evaluation for recruitment, or delirium at the baseline (positive Confusion Assessment Method for ICU) will be excluded. Individuals with cerebral death, aphasia, severe hearing deficit, a prediction of ICU length of stay \< 48 hours, exclusively palliative treatment, or without a familiar member able to participate in extended ICU visits and those who are prisioners, unlikely to survive >24hs, re-admitted to the ICU after enrolment in the study will also be excluded.
  • For Patient's Family Members: Another ICU patient's relative enrolled in the study; family members who don't speak Portuguese; Difficulty to answer the self-administered questionnaires (e.g.: illiteracy)
  • For ICU Workers: ICU workers who have a prediction of withdrawal of ICU care activities >15 days during the study will be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
1,650 participants (actual)

Study arms

  • Active comparator
    Flexible Family Visitation Model (FFVM)

    In the FFVM, two or fewer family members will be allowed to visit the patient for up to 12 consecutive hours each day. In addition to family visitation, patients will be allowed to receive social visits in specific time intervals (according local ICU regulation). To have access to the FFVM, family members of ICU patients will have to attend a structured meeting at ICU in which they will receive orientations about the ICU environment, common ICU treatments, rehabilitation and basic infection control practices, multidisciplinary work at ICU and palliative treatment. Social visitors will not be required to attend the structured meeting.

    Other: Flexible Family Visitation Model (FFVM)

  • Active comparator
    Restrictive Family Visitation Model (RFVM)

    In the RFVM, patients will be allowed to receive restricted visits according routine ICU practices, but respecting the maximum limit of 4.5 hours of visitation per day. Visitors will not be required to attend the structured meeting. The length of ICU visits will be similar to those of social visits in the FFVM.

    Other: Restrictive Family Visitation Model (RFVM)

Interventions

  • OtherFlexible Family Visitation Model (FFVM)

    Visitation to ICU patients allowed during the period of 12 consecutive hours per day.

  • OtherRestrictive Family Visitation Model (RFVM)

    Visitation to ICU patients allowed during intermittent periods according local ICU regulation.

06

What researchers measure

Primary outcomes

  1. Incidence of Delirium among ICU patients

    Incidence of delirium will be verified by trained intensive care professionals with the confusion assessment method for the ICU 2 times per day.

    Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)

Secondary outcomes

  1. Daily hazard of delirium among ICU patients

    The daily hazard of delirium will be analyzed using a joint survival model that accounts for the treatment effect on repeated daily indicator of delirium (Confusion Assessment Method for the ICU) within each patient and terminating event (death or discharge from the ICU).

    Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)

  2. Antipsychotic use among ICU patients

    Need of antipsychotic use during ICU stay

    Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)

  3. Need of mechanical restraints among ICU patients

    Need of mechanical restraints among ICU patients during ICU stay

    Time frame: During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up)

  4. Coma-free days at day 7 among ICU patients

    Days alive and free of coma (Richmond Agitation Sedation Scale -4 or -5) during ICU stay.

    Time frame: During the first 7 days following patient enrollment.

  5. Unplanned loss of invasive devices among ICU patients

    Unplanned loss of venous catheter, tube feeding or urinary catheter

    Time frame: During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up)

  6. Mechanical ventilation-free days at day 7 among ICU patients

    Days alive and free of mechanical ventilation during ICU stay.

    Time frame: During the first 7 days following patient enrollment.

  7. Any ICU-acquired infection among ICU patients

    Pneumonia or bloodstream infection or urinary tract infection acquired after 48 hours of ICU admission.

    Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)

  8. ICU-acquired pneumonia among ICU patients

    Pneumonia acquired after 48 hours of ICU admission.

    Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)

  9. ICU-acquired bloodstream infection among ICU patients

    Bloodstream infection acquired after 48 hours of ICU admission.

    Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)

  10. ICU-acquired urinary tract infection among ICU patients

    Urinary tract infection acquired after 48 hours of ICU admission.

    Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)

  11. ICU length of stay among ICU patients

    Length of ICU stay in days

    Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)

  12. All-cause hospital mortality among ICU patients

    rates of all-cause mortality during hospital stay

    Time frame: During hospital stay (from enrollment until hospital discharge, or death or a maximum of 30 days of follow-up)

  13. Symptoms of anxiety among family members

    symptoms of anxiety among family members measured by the Hospital Anxiety and Depression scale

    Time frame: IOn the day of patient discharge from ICU, or death or a maximum of 30 days of follow-up.

  14. Symptoms of depression among family members

    symptoms of depression among family members measured by the Hospital Anxiety and Depression scale

    Time frame: On the day of patient discharge from ICU, or death or a maximum of 30 days of follow-up.

  15. Satisfaction among among family members

    Rates of patient's families satisfaction measured by the critical care family needs inventory

    Time frame: On the day of patient discharge from ICU, or death or a maximum of 30 days of follow-up.

  16. Prevalence of Burnout Syndrome among ICU professionals

    Prevalence of Burnout Syndrome among ICU workers measured by the Maslach Burnout Inventory

    Time frame: It will be measured in two moments: within 15 days prior to the first ICU intervention and between the 15th and 30th days of the period in which no patient will be enrolled.

  17. Satisfaction with the current ICU visiting policy among ICU professionals

    Satisfaction with the current ICU visiting policy among ICU professionals

    Time frame: It will be measured between the 15th and 30th days of the period in which no patient will be enrolled.

  18. Any adverse event related to ICU visitation

    Any adverse event possible related to the ICU visitation model

    Time frame: During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up)

07

Study locations

33 sites
  • Hospital de Urgência e Emergência de Rio Branco
    Rio Branco, AC, Brazil
  • Fundação Hospital Adriano Jorge
    Manaus, AM, Brazil
  • Hospital Geral Clériston Andrade
    Feira De Santana, BA, Brazil
  • Hospital INCARDIO
    Feira De Santana, BA, Brazil
  • Hospital de Urgências de Goiânia
    Goiânia, Goias, Brazil
  • Hospital das Clínicas da Universidade Federal de Minas Gerais
    Belo Horizonte, MG, Brazil
  • Santa Casa de Misericórdia de São João Del Rei
    São João Del Rei, MG, Brazil
  • Hospital Regional do Baixo Amazonas
    Santarém, PA, Brazil
  • Hospital Universitário Alcides Carneiro
    Campina Grande, PB, Brazil
  • Hospital Universitário Lauro Wanderley
    João Pessoa, PB, Brazil
  • Hospital Universitário de Petrolina
    Petrolina, PE, Brazil
  • Hospital Agamenom Magalhães
    Recife, PE, Brazil
  • Hospital Universitário da Universidade Federal do Piauí
    Teresina, PI, Brazil
  • Hospital do Caâncer de Cascavel (UOPECCAN)
    Cascavel, PR, Brazil
  • Hospital Universitário do Oeste do Paraná (UNIOESTE)
    Cascavel, PR, Brazil
  • Hospital Geral de Nova Iguaçú
    Nova Iguaçú, RJ, Brazil
  • Hospital Deoclécio Marques de Lucena
    Parnamirim, RN, Brazil
  • Hospital Tacchini
    Bento Gonçalves, RS, Brazil
  • Hospital São Camilo de Esteio
    Esteio, RS, Brazil
  • Hospital da Cidade de Passo Fundo
    Passo Fundo, RS, Brazil
  • Hospital de Clínicas de Porto Alegre
    Porto Alegre, RS, Brazil
  • Hospital Dom Vicente Scherer
    Porto Alegre, RS, Brazil
  • Hospital Mãe de Deus
    Porto Alegre, RS, Brazil
  • Hospital Nossa Senhora da Conceiçaão
    Porto Alegre, RS, Brazil
  • Hospital Santa Rita
    Porto Alegre, RS, Brazil
  • Pavilhão Pereira Filho
    Porto Alegre, RS, Brazil
  • Hospital Ana Nery
    Santa Cruz Do Sul, RS, Brazil
  • Hospital Santa Cruz
    Santa Cruz Do Sul, RS, Brazil
  • Hospital Dona Helena
    Joinville, SC, Brazil
  • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
    Ribeirão Preto, SP, Brazil
  • Hospital do Coração (HCor)
    São Paulo, SP, Brazil
  • Hospital Alberto Urquiza Wanderley (UNIMED João Pessoa)
    João, Brazil
  • Hospital Montenegro
    Montenegro, Brazil
08

References and documents

Publications

  • Rosa RG, Falavigna M, Robinson CC, da Silva DB, Kochhann R, de Moura RM, Santos MMS, Sganzerla D, Giordani NE, Eugenio C, Ribeiro T, Cavalcanti AB, Bozza F, Azevedo LCP, Machado FR, Salluh JIF, Pellegrini JAS, Moraes RB, Hochegger T, Amaral A, Teles JMM, da Luz LG, Barbosa MG, Birriel DC, Ferraz IL, Nobre V, Valentim HM, Correa E Castro L, Duarte PAD, Tregnago R, Barilli SLS, Brandao N, Giannini A, Teixeira C; ICU Visits Study Group Investigators and the BRICNet. Study protocol to assess the effectiveness and safety of a flexible family visitation model for delirium prevention in adult intensive care units: a cluster-randomised, crossover trial (The ICU Visits Study). BMJ Open. 2018 Apr 13;8(4):e021193. doi: 10.1136/bmjopen-2017-021193. PubMed 29654049 ↗
  • Sganzerla D, Teixeira C, Robinson CC, Kochhann R, Santos MMS, de Moura RM, Barbosa MG, da Silva DB, Ribeiro T, Eugenio C, Schneider D, Mariani D, Jeffman RW, Bozza F, Cavalcanti AB, Azevedo LCP, Machado FR, Salluh JI, Pellegrini JAS, Moraes RB, Damiani LP, da Silva NB, Falavigna M, Rosa RG. Statistical analysis plan for a cluster-randomized crossover trial comparing the effectiveness and safety of a flexible family visitation model for delirium prevention in adult intensive care units (the ICU Visits Study). Trials. 2018 Nov 19;19(1):636. doi: 10.1186/s13063-018-3006-8. PubMed 30454019 ↗
  • Rosa RG, Pellegrini JAS, Moraes RB, Prieb RGG, Sganzerla D, Schneider D, Robinson CC, Kochhann R, da Silva DB, Amaral A, Prestes RM, Medeiros GS, Falavigna M, Teixeira C. Mechanism of a Flexible ICU Visiting Policy for Anxiety Symptoms Among Family Members in Brazil: A Path Mediation Analysis in a Cluster-Randomized Clinical Trial. Crit Care Med. 2021 Sep 1;49(9):1504-1512. doi: 10.1097/CCM.0000000000005037. PubMed 33870915 ↗
  • Rosa RG, Falavigna M, da Silva DB, Sganzerla D, Santos MMS, Kochhann R, de Moura RM, Eugenio CS, Haack TDSR, Barbosa MG, Robinson CC, Schneider D, de Oliveira DM, Jeffman RW, Cavalcanti AB, Machado FR, Azevedo LCP, Salluh JIF, Pellegrini JAS, Moraes RB, Foernges RB, Torelly AP, Ayres LO, Duarte PAD, Lovato WJ, Sampaio PHS, de Oliveira Junior LC, Paranhos JLDR, Dantas ADS, de Brito PIPGG, Paulo EAP, Gallindo MAC, Pilau J, Valentim HM, Meira Teles JM, Nobre V, Birriel DC, Correa E Castro L, Specht AM, Medeiros GS, Tonietto TF, Mesquita EC, da Silva NB, Korte JE, Hammes LS, Giannini A, Bozza FA, Teixeira C; ICU Visits Study Group Investigators and the Brazilian Research in Intensive Care Network (BRICNet). Effect of Flexible Family Visitation on Delirium Among Patients in the Intensive Care Unit: The ICU Visits Randomized Clinical Trial. JAMA. 2019 Jul 16;322(3):216-228. doi: 10.1001/jama.2019.8766. PubMed 31310297 ↗

Individual participant data

Plan to share: Undecided — The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 23, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02932358
Lead sponsor
Hospital Moinhos de Vento
Collaborators
Ministry of Health, Brazil
Responsible party
Sponsor
First posted
Oct 13, 2016
Start date
Apr 28, 2017
Primary completion
Jun 22, 2018
Completion
Jun 22, 2018
Last update
Nov 23, 2018

Study contacts

Regis Rosa, MD, PhD
principal investigator · Hospital Moinhos de Vento

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion